Furthermore, Bregs TGF-beta production can drive conversion of CD4+ T cells to Tregs leading to inhibition of CD8+ T cells and Natural Killer (NK) cells, both of which are important for limiting tumor growth (49, 50). The gene discussed is CD4; the disease is neoplasm.